Common Misconceptions About Peptides (and Why They Persist)
The eight things people most often get wrong about peptides, from 'they're basically steroids' to 'if it worked in rats it works in me,' each corrected with what the evidence actually shows.
A corrections guide. Each point rests on the evidence covered elsewhere on the site: FDA-approved peptides with Phase III data at one end, single animal studies at the other, and published reviews of how often animal results translate.
- Covers
- peptides vs steroids, legal status, animal-to-human translation, dose and safety, how to weigh testimonials
Why this page exists
Peptides sit in an odd spot: sold like supplements, discussed like drugs, regulated like neither, and explained mostly by the people selling them. That produces a set of beliefs that get repeated until they sound like facts. Here are the eight most common, and what is actually true.
1. “Peptides are basically steroids”
No. Anabolic steroids are copies of testosterone that act on the androgen receptor throughout the body and shut down your own testosterone. Peptides are short chains of amino acids that act as signals; the ones people take raise growth hormone, dampen appetite, or promote healing, and with rare exceptions they do not touch testosterone at all. The confusion comes from shared vendors and shared forums, and from MK-677, which is sold next to SARMs and is neither a SARM nor a peptide. Full comparison: peptides vs SARMs vs steroids.
2. “All peptides are illegal”
Some are prescription drugs: semaglutide, tirzepatide, tesamorelin, PT-141. Most research peptides are legal to sell “for research” and not approved for people, a gray zone rather than a ban. Almost none are controlled substances. What is illegal is selling them as drugs or supplements for human use, which is where FDA warning letters land. Sports bodies are a separate matter: WADA bans growth hormone peptides regardless of legal status.
3. “If it works in rats, it works in humans”
This is the one that matters most. Rat metabolism, tissue repair, and receptor distribution differ from ours; animal studies use small groups and publish the positive results; and the doses often do not scale. A systematic review found animal results predicted the later human result only about half the time (Hackam & Redelmeier, 2006), and across drug development roughly 90% of compounds that enter human trials never reach approval (Hay et al., 2014). AOD-9604 cut fat in half in mice and did nothing in a 300-person trial. A rat result is where the question starts. See how peptides are studied.
4. “Natural means safe”
Your body makes insulin; the wrong dose is fatal. Your body makes LL-37; too much drives psoriasis and lupus. Being a copy of a natural molecule tells you nothing about what a pharmacological dose, injected, does. And most research peptides are not natural anyway: they are modified copies built to last longer. See the safety guide.
5. “More is better”
Signals saturate. Once every receptor is occupied, extra peptide does nothing useful and everything harmful. Growth hormone peptides desensitize with overuse, hexarelin fastest of all. Community doses for most research peptides come from forum consensus, not dose-finding studies, and the safe upper limit for most of them has never been measured in a person.
6. “Peptides are unregulated”
They are regulated; the regulation is just uneven. Approved peptides go through the full FDA process. The FDA has restricted compounding of several research peptides, including BPC-157, and sends warning letters to vendors selling them for human use. What is missing is any quality control on the research-chemical market itself, which is a different problem: the peptide is regulated, the vial you bought is not.
7. “Peptides are FDA approved for bodybuilding or anti-aging”
No peptide is approved for either. The approvals that exist are for diabetes, obesity, HIV-related belly fat, low sexual desire, and a few other specific conditions. “FDA approved” on a vendor page for ipamorelin or epithalon is false, and “pharmaceutical grade” is a marketing phrase with no regulatory meaning.
8. “The influencer tried it and it worked”
One person, no control group, a financial interest in the outcome, and usually a training and diet program running at the same time. Testimonials cannot separate the peptide from everything else the person changed, cannot detect placebo, and never come from the people it did not work for. This is also true of forum consensus, which is thousands of testimonials with the failures filtered out. The claims guide shows what to look for instead.
Why these persist
Every belief on this list makes peptides easier to sell. Vendors have no incentive to correct them, forums reward enthusiasm, and the real evidence lives in papers most people never read. The peptide industry has grown faster than the science behind most of its products (Fosgerau & Hoffmann, 2015), and the gap is filled with stories. This site exists to grade the evidence peptide by peptide so the stories have something to be checked against.
Frequently Asked Questions
Are peptides safer than steroids?
Different, not automatically safer. An approved peptide with trial data is a known quantity; a research peptide of unknown purity is not. Compare specific compounds.
Is it legal to buy research peptides?
In most places, yes, as research chemicals. Using them on yourself is unregulated rather than illegal. Selling them for human use is what draws enforcement.
Which peptides actually have human evidence?
Semaglutide, tirzepatide, tesamorelin, PT-141, and thymosin alpha-1 have large trials. Sermorelin was an approved drug. Most of the rest have animal data. Every page on this site carries the grade.
References
- Hackam DG, Redelmeier DA. (2006). Translation of research evidence from animals to humans. JAMA. PubMed
- Hay M, et al. (2014). Clinical development success rates for investigational drugs. Nat Biotechnol. PubMed
- Fosgerau K, Hoffmann T. (2015). Peptide therapeutics: current status and future directions. Drug Discov Today. PubMed